Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:TARO

Taro Pharmaceutical Industries (TARO) Stock Price, News & Analysis

Taro Pharmaceutical Industries logo

About Taro Pharmaceutical Industries Stock (NYSE:TARO)

Advanced Chart

Key Stats

Today's Range
$42.97
$42.97
50-Day Range
$42.20
$42.99
52-Week Range
$32.67
$45.76
Volume
N/A
Average Volume
45,199 shs
Market Capitalization
$1.62 billion
P/E Ratio
29.84
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive TARO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Taro Pharmaceutical Industries and its competitors with MarketBeat's FREE daily newsletter.

TARO Stock News Headlines

Top Picks for Trump’s Pro-Crypto America
Mark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…
See More Headlines

TARO Stock Analysis - Frequently Asked Questions

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) released its quarterly earnings results on Thursday, October, 28th. The company reported $0.66 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.02 by $0.36. The firm had revenue of $131.99 million for the quarter, compared to the consensus estimate of $153.23 million. Taro Pharmaceutical Industries had a net margin of 8.56% and a trailing twelve-month return on equity of 3.75%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Taro Pharmaceutical Industries investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Advanced Micro Devices (AMD), Adobe (ADBE), ServiceNow (NOW) and Arista Networks (ANET).

Company Calendar

Last Earnings
10/28/2021
Today
7/03/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NYSE:TARO
Employees
1,554
Year Founded
N/A

Profitability

Trailing P/E Ratio
29.84
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$53.87 million
Pretax Margin
13.14%

Debt

Sales & Book Value

Annual Sales
$629.18 million
Cash Flow
$2.38 per share
Price / Cash Flow
18.03
Book Value
$47.70 per share
Price / Book
0.90

Miscellaneous

Free Float
32,400,000
Market Cap
$1.62 billion
Optionable
Optionable
Beta
0.56
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NYSE:TARO) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners